AI Article Synopsis
- * Despite negative family screening tests, she was eventually diagnosed with WD at age 68 after a liver biopsy and genetic testing.
- * The case highlights that individuals with liver issues and a family history of WD should undergo thorough medical examinations, as the disease can develop at any age.
Article Abstract
A 73-year-old woman was referred to our hospital for persistent liver dysfunction. When the patient was 45 years old, her youngest sister had been diagnosed with Wilson disease (WD). The patient therefore underwent several family screening tests, all of which were unremarkable. She had an annual medical checkup and was diagnosed with liver dysfunction and fatty liver at 68 years old. A liver biopsy and genetic testing were performed, and she was diagnosed with WD; chelation therapy was then initiated. In patients with hepatic disorders and a family history of WD, multiple medical examinations should be conducted, as the development of WD is possible regardless of age.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10824639 | PMC |
| http://dx.doi.org/10.2169/internalmedicine.1789-23 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A machine learning-assisted systematic review of preclinical glioma modeling: Is practice changing with the times?
Neurooncol Adv
December 2024
Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Background: Despite improvements in our understanding of glioblastoma pathophysiology, there have been no major improvements in treatment in recent years. Animal models are a vital tool for investigating cancer biology and its treatment, but have known limitations. There have been advances in glioblastoma modeling techniques in this century although it is unclear to what extent they have been adopted.
View Article and Find Full Text PDFSmall Animal Dermatology: Updates on Canine Atopic Dermatitis, Cutaneous Infectious Disease, Autoimmune Disease, and Treatment Modalities.
Vet Clin North Am Small Anim Pract
December 2024
Gulf Coast Veterinary Specialists, 8042 Katy Freeway, Houston, TX 77024, USA. Electronic address:
Pediatric Neurosonography: Comprehensive Review and Systematic Approach.
Can Assoc Radiol J
December 2024
Department of Diagnostic and Intervention Radiology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Neurosonography (NSG) is pivotal for rapid, point-of-care neonatal brain assessment. This review elucidates the comprehensive applications of NSG in pediatric care, emphasizing its role in early diagnosis and management of pathologies affecting the pediatric head-such as scalp lesions, misshapen calvarium, ventricular distortions, and cerebrovascular abnormalities, and its specific role in conditions like hypoxic-ischaemic encephalopathy (HIE) across different neonatal gestational ages. We explore its diagnostic advantage in critical care settings, particularly for infants with stroke risk in sickle cell disease, ECMO-related complications, screening for therapeutic hypothermia, and routine neonatal intensive care unit monitoring.
View Article and Find Full Text PDFIron and Copper Liver Concentrations in Wilson Disease.
J Gastrointestin Liver Dis
December 2024
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Background And Aims: Wilson disease (WD) results in the defective incorporation of copper into ceruloplasmin as well as decreased biliary copper excretion. Secondary iron overload has also been associated with WD; however, the prevalence is currently unknown. This study aims to determine the prevalence of potential secondary iron overload in patients suspected to have WD.
View Article and Find Full Text PDFA Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons.
J Viral Hepat
February 2025
Centre for Public Health and Epidemiology, School of Medicine, University of Nottingham, Nottingham, UK.
The prevalence of viral hepatitis among people in prisons is higher than in the general population. Screening, treatment and vaccination programmes exist within prisons to reduce the incidence of hepatitis, although lower uptake has often been reported compared to similar programmes outside of prisons. We conducted a systematic review of qualitative evidence to explore the barriers and facilitators to hepatitis B and C reduction programmes in prisons from the perspectives of people in prison, custodial staff and prison healthcare staff.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!